Fatty Liver Disease - How It Is Diagnosed and What the Tests Mean
Fatty liver disease is often first discovered incidentally, but the bigger question is what happens next. This page is designed to help patients and GPs understand the diagnostic pathway without turning every abnormal result into panic.
Content note
Prepared by the Elastography Australia clinical education team for informational purposes and pathway literacy. It is not patient-specific medical advice.
- Fatty liver is often found incidentally on ultrasound or routine blood work rather than because the patient has clear symptoms.
- The important next step is to separate simple steatosis from clinically important fibrosis risk.
- Elastography becomes valuable when the clinician needs a better sense of fibrosis and steatosis burden without jumping straight to biopsy.
- Fatty liver often has no obvious symptoms at first and is commonly found during unrelated tests.
- An abnormal scan or blood test does not automatically mean severe liver damage, but it does mean the liver should be assessed properly.
- Ask what your blood tests, fibrosis risk score, and scan results mean together, not one by one.
Why fatty liver is often found by accident
Many patients discover fatty liver after abnormal liver enzymes, a routine health check, or an abdominal ultrasound done for another reason. That is one reason this page is positioned in plain language rather than specialist-only terminology.
What tests are used
The typical workup includes blood tests, risk scores such as FIB-4, imaging such as ultrasound, and sometimes elastography when fibrosis needs to be staged more clearly.
Biopsy is no longer the first answer for most people because non-invasive pathways are often safer and more practical.
- Blood tests help estimate inflammation and broader liver risk.
- Ultrasound can suggest fatty change but not stage fibrosis well on its own.
- Elastography helps estimate fibrosis and, on some systems, steatosis severity.
What results can mean
The most important question is whether there is only fat in the liver or whether fibrosis is already developing. That is why kPa values, FIB-4, and attenuation measures such as CAP or UAP matter in context.
A GP or specialist should explain whether the result is low-risk, indeterminate, or something that needs referral or further staging.
Next steps after diagnosis
Management often includes lifestyle change, metabolic risk reduction, repeat testing, and specialist review when fibrosis risk is higher. The practical value of guided elastography is that it can support clearer staging and follow-up without making every patient go through a hospital referral first.
Related pages
Next steps for clinicians